Search Results
Results found for "Raymond Stevens"
Posts (29)
- ShouTi Pharma CEO Dr. Raymond Stevens was interviewed by Moira Gunn of the NPR TechNation podcast
April 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, August 28 to September 3, 2023
X4 Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference CEO Raymond Stevens to Speak at STAT Future Summit on Obesity Therapeutics Call for GPCR Papers NEW opnMe GPCR Route
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
To validate the potential of CELT-335 as a probe, seven reference compounds were selected. Table 2. In Figure 4 coherent and well-defined sigmoidal concentration/response curves can be found for all seven M.; Makriyannis, A.; Stevens, R. C.; Liu, Z.-J. M.; Makriyannis, A.; Stevens, R. C.; Liu, Z.-J. )Â Â Â Â Â Â Â Â Gado, F.; Di Cesare Mannelli, L.; Lucarini, E.; Bertini, S.; Cappelli, E.; Digiacomo, M.; Stevenson
Other Pages (5)
- Martin Audet | Dr. GPCR Ecosystem
Scripps Research in San Diego and the University of Southern California in Los Angeles as a member of Raymond Stevens group.
- Dr. Matthew Eddy | Dr. GPCR Ecosystem
Eddy began learning and investigating human GPCRs while training in the laboratories of Professors Raymond Stevens and Kurt Wüthrich at The Scripps Research Institute.
- Steve McCloskey | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Steve McCloskey About Steve McCloskey Steve McCloskey is Steve’s work is focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Steve McCloskey on the web Website LinkedIn Twitter ResearchGate Medium Orchid Dr.
